Transcription of シスメックス株式会社 - sysmex-labscience.jp
1 NoncliniCal Blood Testing and Cell AnaLysis 2017 3 1 - CBC (Complete blood count) 5 DIFF 6 RET 7 8 A ADP 10 AHF 10 APTT 10 APIII 11 F FDP 11 L LACI 11 P PIC 12 PIVKA 12 PT 12 S SLE 13 T TAT 13 TFPI 13 1 14 2 14 2 15 15 15 16 16 16 2 17 17 17 17 18 18 18 18 3 19 4 19 19 A 19 B 19 BM 20 VIII 20 20 21 21 21 21
2 21 22 22 22 22 I 23 V 23 VII 23 VIII 24 IX 24 X 25 XI 26 XII 26 XIII 27 28 28 28 3 28 A2 28 29 29 29 K 29 30 30 30 31 1 42 31 32 32 32 32 33 34 34 1 35 35 35 C 35 C 36 S 36 37 37 37 38 38 38 38 38 38 4 S SOP 39 39 39 39 39 40 40 40 40 40 40 41 41 41 41 41 41 41 5 I 1 CBC(Complete blood count) (1) WBC White Blood Cell (2) RBC Red Blood Cell (3) HGB Hemoglobin (4) HCT (hematocrit) (5)
3 MCV Mean Corpuscular Volume RBC HCT (6) MCH Mean Corpuscular Hemoglobin RBC HGB (7) MCHC Mean Corpuscular Hemoglobin Concentration HCT HGB (8) PLT Platelet (9) RDW-SD RBC 100% 20% RDW-SD (10) RDW-CV RBC RBC L1 L2 6 (11) PDW PLT PLT 100% 20% PDW (12) MPV LD(Lower Discriminator) UD(Upper Discriminator) MPV (13) P-LCR 12fL LD(Lower Discriminator) UD(Upper Discriminator) (14) PCT PLT 2 DIFF (1) NEUT (#, %) Neutrophil (2)LYMPH (#, %) Lymphocyte (3) MONO (#, %) Monocyte 7 (4) EO (#, %) Eosinophil (5) BASO (#, %) Basophil 3 RET (1) RET Reticulocyte RET# RET% RBC (2) IRF (Immature Reticulocyte Fraction) MFR HFR (3) LFR (Low Fluorescence Ratio) HFR MFR (4) MFR (Middle Fluorescence Ratio) (5) HFR (High Fluorescence Ratio) 8 4 (1) DC RBC,HCT,PLT ( )
4 DC ( 3 ) DC DC DC 1983 (2) SLS-Hb HGB SLS- Sodium LaurLysulfate (C12H25SO4Na; SLS) SLS- (1) SLS (2) SLS9 (3) (4) SLS (3) DIFF,WBC/BASO,RET flow cytoMetry FCM 10 II A (1) ADP Adenosine diphosphate C10H15N5O10P2 ATP ADP GPIIb/III ADP 1 ADP ADP ADP (2)
5 AHF Antihemophilic factor VIII VIII (3) APTT ActiVated PArtial Thromboplastin Time XII PTT 1/9 11 30 45 (4) ATIII AntithrombinIII III 300 g/ml 432 58,200 Xa ATIII 393 ( ) ATIII (Arg13,Lys125, Arg46,Arg47,Lys125, Arg129,Arg132) 750 2 DIC 5,000 ATIII F (1) FDP Fibrin or Fibrinogen degradation products (1) LACI Lipoprotein associated coagulation inhibitor TFPI TFPI 12 (1) PIC Plasmin 2 plasmininhibitor complex - 2 2 6 E A 2 2 PIC g/ml DIC (2)
6 PIVKA Protein induced by vitamin K absence K K II VII IX X C S K NH2 10 Glu Gla K Gla Ca K Gla lu 3 K K K K PT 15 40 10 (3) PT Prothrombin Time VII X V II 13 12 PT DIC PT 20 (1) SLE Lupus anticoagulants LA SLE ELISA APTT APTT (1) TAT Thrombin Anti-ThrombinIII Complex III III III (TAT)
7 TAT ATIII TAT ELISA DIC DIC (2) TFPI Tissue factor PAthway inhibitor LACI 2 VLDL HDL 276 3 Kunitz 42,000 4 VIIa X 2 Kunitz Xa 1 Kunitz VIIa VIIa X IX 5 100ng/ml 14 (1) 1 alpha antitrypsin 1 AT 50,000 150 350mg/dl IXa Xa 2 2 Plasmin inhibitor 2 PI 2- 67,000 2- PI 2- PI C Arg364-Met365 Ser740 15 XIa 70 g/ml 1 2 2- PI 2-MG 2- PI EIA 2- 2- PI DIC.
8 2 2 Macroglobulin 2 MG 2 MG 1,451 180,000 4 726,000 Xa t-PA 2 MG 1 1 1 2 1 4 ATIII 1-AT 1 3mg/ml DIC Thromboglobulin TG 35,000 EIA 10 40ng/ml DIC SLE -TG (1) ArachidoniCacid C20H32O2 MW304 46 2 2 TXB2 2 PG 2 (2) 16 Argatoroban 527 III II (3)
9 Integrin Family 2 6 Arg Gly Asp 2 glycoprotein GP GPIa/IIa GPIIb/IIIa von Willebrand GPIIB/IIIA IIb 3 (4) Urokinase UK Urokinase type plasminogen actiVater u-PA UK Lys158 le159 54,000 7 1 4 33,000 UK UK Lys134 Lys135 N 143 17 (1) ActiVated PArtial thromboplastin time APTT APTT (2) Soluble fibrin monomer complex SFMC SFMC SFMC DIC SFMC SFMC O Rh SFMC FM SFMC 20 g/ml (3) Calci
